Skip to main content
. Author manuscript; available in PMC: 2014 May 5.
Published in final edited form as: J Infect Dis. 2005 Jul 12;192(4):658–664. doi: 10.1086/432076

Table 2.

Demographic and clinical characteristics of the SV40-excreting patients.

Patient (age in months, sex) Race/ethnicity Diagnosis/treatment Immune compromised
1 (4.5, male) Hispanic Influenza A infection, sepsis, empyema No
2 (4.5, male) Hispanic Gastroenteritis No
3 (27, male) Hispanic Bacteremia, fungemia, respiratory syncytial virus bronchiolitis No
4 (29, male) White Rhabdomyosarcoma (chemotherapy) Yes
5 (33, female) Hispanic Neuroblastoma (chemotherapy) Yes
6 (41.5, male) Hispanic Hemophagocytic syndrome (bone-marrow transplant) Yes
7 (60, male) Hispanic Acute lymphoblastic leukemia (bone-marrow transplant) Yes
8 (162, male) Other/mixed Cystic fibrosis (lung transplant) Yes